BioSpace News Archive

The latest market analysis report published by Reports and Data, titled ‘Global Cluster Headache Market – Forecast to 2030,’ thoroughly examines the Cluster Headache industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Cushing Syndrome Market – Forecast to 2030,’ thoroughly examines the Cushing Syndrome industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Allergic Dermatitis Market – Forecast to 2030,’ thoroughly examines the Allergic Dermatitis industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Burkitt Lymphoma Market – Forecast to 2030,’ thoroughly examines the Burkitt Lymphoma industry to provide essential data & information for the targeted readers.

The global Biophotonics Market is projected to reach USD 118.89 billion by 2027, according to a recent report by Emergen Research. The growing demand for this technology in the healthcare sector is driving the growth of the market.

According to the current analysis of Emergen Research, the global Diabetic Ketoacidosis Market was valued at USD 1297.3 million in 2019 and is expected to reach USD 1973.6 million by 2027, at a CAGR of 6.2%.

The global Point-Of-Care Testing (POCT) market size reached USD 39.80 Billion in 2021 and is expected to register a revenue CAGR of 10.9% during the forecast period, according to latest analysis by Emergen Research.

Human epidermal development factor receptor 2 (HER2) is a gene that is connected to breast cancer improvement. Genes contain the recipes for various proteins expected by a cell to stay solid and capacity typically.

Vuzix® Corporation announced that its M400 smart glasses are currently being trialed in Japan for an emergency medical care plan with the objective of providing early treatment in an effort to improve patient outcomes and lifesaving rates for critically ill patients undergoing transport to the hospital.

InnerScope Hearing Technologies Inc. is pleased to announce that the FDA has released the “Final Rule” for creating a new category of Over-the-Counter hearing aids for perceived mild to moderate hearing losses to be sold directly to consumers in retail stores, pharmacies and online without a medical exam or being fitted by a hearing healthcare professional.